These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26722203)

  • 1. Pancreatic Neuroendocrine Tumors: an Update.
    Paniccia A; Edil BH; Schulick RD
    Indian J Surg; 2015 Oct; 77(5):395-402. PubMed ID: 26722203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Well-differentiated G1 and G2 pancreatic neuroendocrine tumors: a meta-analysis of published expanded DNA sequencing data.
    Andersen KØ; Detlefsen S; Brusgaard K; Christesen HT
    Front Endocrinol (Lausanne); 2024; 15():1351624. PubMed ID: 38868744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for metastatic pancreatic neuroendocrine tumors.
    Rossi RE; Massironi S; Conte D; Peracchi M
    Ann Transl Med; 2014 Jan; 2(1):8. PubMed ID: 25332984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of surgical resection for pancreatic neuroendocrine tumors.
    Doi R
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors.
    Nuñez JE; Donadio M; Filho DR; Rego JF; Barros M; Formiga MN; Lopez R; Riechelmann R
    J Gastrointest Oncol; 2019 Aug; 10(4):645-651. PubMed ID: 31392045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
    Ito T; Lee L; Hijioka M; Kawabe K; Kato M; Nakamura K; Ueda K; Ohtsuka T; Igarashi H
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):574-7. PubMed ID: 25689058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroenteropancreatic neuroendocrine tumors: update on therapeutics.
    Ganetsky A; Bhatt V
    Ann Pharmacother; 2012 Jun; 46(6):851-62. PubMed ID: 22589450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the Surgical Treatment of Pancreatic Neuroendocrine Tumors.
    Jeune F; Taibi A; Gaujoux S
    Scand J Surg; 2020 Mar; 109(1):42-52. PubMed ID: 31975647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine tumors of the pancreas.
    Milan SA; Yeo CJ
    Curr Opin Oncol; 2012 Jan; 24(1):46-55. PubMed ID: 22080942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pancreatic neuroendocrine tumors in patients with MEN 1.
    Sadowski SM; Triponez F
    Gland Surg; 2015 Feb; 4(1):63-8. PubMed ID: 25713781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs.
    van Vliembergen ENM; Eijkelenkamp H; Valk GD; Vriens MR; Meijer GJ; Intven MPW; de Laat JM
    Front Endocrinol (Lausanne); 2023; 14():994370. PubMed ID: 37305036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature.
    Sadowski SM; Pieterman CRC; Perrier ND; Triponez F; Valk GD
    Endocr Relat Cancer; 2020 Jun; 27(6):R145-R161. PubMed ID: 32229700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of spontaneous pancreatic neuroendocrine tumors.
    Yu R
    Mol Cell Endocrinol; 2016 Feb; 421():60-7. PubMed ID: 26261055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of pancreatic neuroendocrine tumors.
    Grozinsky-Glasberg S; Mazeh H; Gross DJ
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):578-85. PubMed ID: 25689919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First surgery for pancreatic neuroendocrine tumours in a patient with MEN1: enucleation versus disease-modifying surgery.
    Harper S; Harrison B
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):618-21. PubMed ID: 25807996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1.
    Niina Y; Fujimori N; Nakamura T; Igarashi H; Oono T; Nakamura K; Kato M; Jensen RT; Ito T; Takayanagi R
    Gut Liver; 2012 Jul; 6(3):287-94. PubMed ID: 22844555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic neuroendocrine tumors.
    Batcher E; Madaj P; Gianoukakis AG
    Endocr Res; 2011; 36(1):35-43. PubMed ID: 21226566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET).
    Yang G; Ji M; Chen J; Chen R; Chen Y; Fu D; Hou B; Huang H; Jiang L; Jin K; Ke N; Li Y; Li Y; Liang H; Liu A; Luo J; Ni Q; Shao C; Shen B; Sheng W; Song B; Sun J; Tan C; Tan H; Tang Q; Tang Y; Tian X; Wang J; Wang J; Wang W; Wang W; Wu Z; Xu J; Yan Q; Yang N; Yang Y; Yin X; Yu X; Yuan C; Zeng S; Zhang G; Zhang R; Zhou Z; Zhu Z; Shao C
    Int J Oncol; 2017 Feb; 50(2):567-574. PubMed ID: 28035372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review.
    Chang JY; Ruff SM; Cloyd JM
    Chin Clin Oncol; 2024 Apr; 13(2):25. PubMed ID: 38711178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgery for pancreatic neuroendocrine tumors].
    Shibata C; Egawa S; Motoi F; Morikawa T; Naitoh T; Unno M; Sasaki I
    Nihon Geka Gakkai Zasshi; 2012 Nov; 113(6):502-6. PubMed ID: 23330458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.